FATE Stock-Based Compensation
Fate Therapeutics Inc · Stock-Based Compensation
FATE Stock-Based Compensation
Latest reported$17.84Mperiod ending
FATE Stock-Based Comp ($172.00K → $17.84M)
Annual stock-based compensation
High-resolution chart · PNG
FATE stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 24,924,000 | |
| 41,496,000 | |
| 43,459,000 | |
| 78,733,000 | |
| 54,364,000 | |
| 30,753,000 | |
| 17,410,000 | |
| 6,293,000 | |
| 3,606,000 | |
| 3,184,000 | |
| 2,400,000 | |
| 2,434,000 | |
| 1,554,000 | |
| 155,000 | |
| 172,000 |